This is an extremely interesting stock.
At this stage of the game, we know it works, approvals are in, the product is only just starting to get traction within the mainstream medical community. All in all, it seems to be at an inflexion point, much like CSL when it was a few dollars. The CR funds will be used to push the commercialisation.
Missed the run up, and the pullback on the CR seems like an incredible buying opportunity. What am I missing?
Ann: Institutional Placement of A$120.0 Million, page-53
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.68 |
Change
0.150(4.25%) |
Mkt cap ! $257.1M | |||
| Open | High | Low | Value | Volume |
| $3.69 | $3.77 | $3.61 | $917.4K | 248.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 587 | $3.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.68 | 1999 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |